Publications by authors named "Manlio Sgarzi"
Article Synopsis
- * Current treatments can have side effects and don't always work well for everyone, so there's a big need for better options.
- * A new drug called eculizumab has been approved in Italy and might help those who don’t respond to standard treatments, and experts think it could meet the needs of many patients with MG.
Article Synopsis
- The study examined the epidemiology, management, and economic impact of myasthenia gravis using data from about 12 million people in Italy from 2011 to 2018.
- It found that the prevalence of myasthenia gravis in 2018 ranged from 13.5 to 29.3 cases per 100,000 people, with a population estimate of 8,190 to 17,728 affected individuals.
- Treatment indications revealed high usage of pyridostigmine (84%) and corticosteroids (54%), with healthcare costs for myasthenia gravis patients being four times greater than the general population, significantly increasing for those experiencing exacerbations.
Objectives: Evidences from either small series or spontaneous reporting are accumulating that SARS-CoV-2 involves the Nervous Systems. The aim of this study is to provide an extensive overview on the major neurological complications in a large cohort of COVID-19 patients.
Methods: Retrospective, observational analysis on all COVID-19 patients admitted from February 23rd to April 30th, 2020 to ASST Papa Giovanni XXIII, Bergamo, Italy for whom a neurological consultation/neurophysiological assessment/neuroradiologic investigation was requested.